Long-time remission of laryngeal Rosai–Dorfman disease with thalidomide: a report of three cases-Reference-Cited by-同舟云学术

Long-time remission of laryngeal Rosai–Dorfman disease with thalidomide: a report of three cases

Published:2021-01-01 Issue:1 Volume:26 Page:552-555
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Wei Chong¹^ORCID,Zhou Dao-bin¹

Affiliation:

1. Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People’s Republic of China

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2021.1941552

Reference20 articles.

1. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

2. Review of Rosai-Dorfman Disease: New Insights into the Pathogenesis of This Rare Disorder

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lenalidomide and dexamethasone for Rosai-Dorfman disease: a single arm, single center, prospective phase 2 study;eClinicalMedicine;2024-07

2. Sinus histiocytosis of non-langerhans cell type with obstruction of the subglottic and tracheal region (Rosai—Dorfman disease);Onkologiya. Zhurnal imeni P.A.Gertsena;2024

3. Clinical features, diagnosis, treatment and prognosis of otolaryngological extranodal sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease, RDD);European Archives of Oto-Rhino-Laryngology;2022-09-25

4. Rosai-Dorfman disease;Saudi Medical Journal;2022-04

5. Successful treatment of multisystemic Rosai-Dorfman disease with lenalidomide and dexamethasone: a case report;Annals of Hematology;2021-11-06